New immunotherapy-targeted combination improves survival in metastatic colorectal cancer
A landmark trial led by UCLA Health investigators has demonstrated that combining a targeted therapy drug Zanzalintinib with…
A landmark trial led by UCLA Health investigators has demonstrated that combining a targeted therapy drug Zanzalintinib with…